Kerala Ayurveda last traded at ₹151.55 (2026-10-13). Over the past month the stock moved -15.8%, three months the stock moved -26.6%, year the stock moved -68.2%. Its closing range over 52 weeks is ₹143.20 – ₹430.05, with the latest close 64.8% below the high.
Closing prices up to 2026-10-13.
Incorporated in 1945, Kerala Ayurveda Ltd is engaged In Ayurvedlc services and products[1]
Business Overview:[1] Company manufactures Ayurveda products and deals in Ayurveda Research, Academies, Clinics, Hospitals, Ayurvedic Wellness Resorts and Services, cultivation of Ayurveda herbs, and maintaining a herbarium of medicinal plants
In the latest quarter (Jun 2026), Kerala Ayurveda reported sales of ₹33.19 crore (+16.0%) and net profit of ₹-8.08 crore (-498.0%), compared with the same quarter last year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Jun 2026 | 33.19 | -3.83 | -11.54 | -8.08 | -6.14 |
| Mar 2026 | 34.74 | -7.10 | -20.44 | -7.39 | -5.97 |
| Dec 2025 | 32.96 | -1.51 | -4.58 | -4.60 | -3.69 |
| Sep 2025 | 34.84 | -4.95 | -14.21 | -6.36 | -5.26 |
| Jun 2025 | 28.61 | -4.19 | -14.65 | 2.03 | 1.65 |
| Mar 2025 | 31.32 | -10.14 | -32.38 | -15.38 | -12.92 |
| Dec 2024 | 31.13 | -1.19 | -3.82 | -2.70 | -2.40 |
| Sep 2024 | 30.41 | 5.53 | 18.18 | 3.65 | 2.84 |
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +21.5% | +18.3% | -2.2% | +4.1% | +14.6% | +5.9% | +10.9% | +16.0% |
| Operating profit growth | +924.1% | -217.8% | -286.1% | -623.8% | -189.5% | – | – | – |
| Net profit growth | – | – | -3001.9% | +341.3% | -274.2% | – | – | -498.0% |
| EPS growth | – | – | -5972.7% | +511.1% | -285.2% | – | – | -472.1% |
| OPM % | 18.2% | -3.8% | -32.4% | -14.7% | -14.2% | -4.6% | -20.4% | -11.5% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
In the latest year (Mar 2026), Kerala Ayurveda reported sales of ₹131.00 crore (+9.2%) and net profit of ₹-16.00 crore, compared with the previous year.
| Period | Sales | Operating profit | OPM % | Net profit | EPS (₹) |
|---|---|---|---|---|---|
| Mar 2026 | 131.00 | -18.00 | -14.00 | -16.00 | -12.74 |
| Mar 2025 | 120.00 | -5.00 | -4.00 | -14.00 | -12.22 |
| Mar 2024 | 108.00 | 7.00 | 6.00 | -1.00 | -1.27 |
| Mar 2023 | 93.00 | 3.00 | 3.00 | 0.00 | -0.85 |
| Mar 2022 | 80.00 | 10.00 | 12.00 | 2.00 | 2.24 |
| Mar 2021 | 62.00 | 1.00 | 1.00 | -5.00 | -4.59 |
| Mar 2020 | 77.00 | 7.00 | 10.00 | 4.00 | 3.69 |
| Mar 2019 | 59.00 | 5.00 | 9.00 | 3.00 | 2.31 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales growth | +0.0% | +30.5% | -19.5% | +29.0% | +16.3% | +16.1% | +11.1% | +9.2% |
| Operating profit growth | -37.5% | +40.0% | -85.7% | +900.0% | -70.0% | +133.3% | -171.4% | – |
| Net profit growth | +0.0% | +33.3% | -225.0% | – | -100.0% | – | – | – |
| EPS growth | -13.2% | +59.7% | -224.4% | – | -137.9% | – | – | – |
| OPM % | 9.0% | 10.0% | 1.0% | 12.0% | 3.0% | 6.0% | -4.0% | -14.0% |
Colour scale: below -5% -5% to 0% 0% to 5% 5% to 20% 20% and above. A dash means the earlier figure was zero or negative, so a percentage is not meaningful.
No AI analysis generated yet for Kerala Ayurveda.
Get Free AI Stock Analysis FREE →Kerala Ayurveda reports consolidated net loss of Rs 7.98 crore in the June 2026 quarter - Business Standard
Kerala Ayurveda shares were last quoted at ₹151.55 (-1.1% on the day). Use the Refresh price button on this page for the latest available price. Prices are for information only.
Kerala Ayurveda has a price-to-earnings (P/E) ratio of -7.77 and a price-to-book (P/B) ratio of 79.82. The industry P/E is 53.33.
The 52-week high of Kerala Ayurveda is ₹484.90 and the 52-week low is ₹145.00.
The market capitalisation of Kerala Ayurveda is about ₹190.17 crore.
In the latest quarter (Jun 2026), Kerala Ayurveda reported sales of ₹33.19 crore (+16.0%) and net profit of ₹-8.08 crore (-498.0%), compared with the same quarter last year.
This page is for information and is not investment advice. As per the data shown here, Kerala Ayurveda has a 3-year ROE of -85.00%. Review the fundamentals, quarterly results and AI analysis on StockSpin, and consult a SEBI-registered adviser before investing.
Promoters hold about 35.60% of Kerala Ayurveda.
Kerala Ayurveda belongs to the Pharmaceuticals & Drugs sector.